baber/WOPTO huggingface dataset:
Patent NZ-548228-A (NZ)
Title: Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
Inventor: XIE WENGE
IPC: A61K31/46
Filed: 2004-12-22
Abstract: Disclosed are compounds of formulae (I), (II) and (III) wherein the substituents are as defined in the specification. The compounds are ligands for nicotinic acetylcholine receptors (nAChR) useful in the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain.
Patent NZ-548920-A (NZ)
Title: Physical user interface
Inventor: COHEN THOMAS ANDREW
IPC: G06F3/02
Filed: 2005-02-11
Abstract: A physical interface (10) for an operating system is disclosed. An array of sensors are located below a workspace (12) that is divided into regions (13) discernible by a user, each region signifying a command to or an action performed by the operating system, and a number of physical tokens (14). Each token is uniquely identifiable by the sensors, and each sensor produces a recognition signal. A signal processor produces a first output associated with the identity of a token and the region that the token is in, determined from the recognition signal. A control program turns the first output signal into a second output signal capable of being interpreted by the operating system as a command.
Patent NZ-549601-A (NZ)
Title: Aiming device for inserting stable-angle, long screws in the articular region of a bone
Inventor: KUENZI THOMAS
Filed: 2004-02-20
Abstract: The disclosure relates to an aiming device (100) for boring a hole in a region of a bone (not shown) that lies in the vicinity of a joint. Said device consists of a U-shaped bow (110) comprising at least one contact element (120) on one end and on the other end of the bow (110) a screw spindle (130) that can be displaced in the direction of, or in the opposite direction to the contact element (120), said spindle comprising a rotary grip (132) for clamping the device (100) on the region in the vicinity of the joint. The device also comprises a bore bushing (140), which can be placed on and removed from the end comprising the contact element (120). The compression of the bone that is generated by the bow (110) is maintained after the removal of the bore bushing (140) for the insertion of the bone screw.
Patent NZ-550194-A (NZ)
Title: Dark-banded vial for use with level where the reflections of the bark bands cause the air/liquid interface of the bubble to be more visible.
Inventor: FORAN THOMAS P
IPC: G01C9/24
Filed: 2005-04-18
Abstract: A vial (10) for use in a level is disclosed. The vial (10) is constructed with a closed body containing a liquid and a bubble, first and second marker rings (41, 42) and first and second dark bands (61, 62). The body has two ends (71, 72), a midpoint (31), and interior and exterior surfaces. The interior surface defines a barrel-shaped cavity, the cavity having a maximum diameter near the midpoint (31). The first and second marker rings (41, 42) are visible from the outside of the vial (10) on either side of the midpoint (31). The first and second dark bands (61, 62) circumscribing the cavity, each band (61, 62) positioned near an end of the body. The interface between the liquid and the bubble reflects the first and second dark bands (61, 62) such that the interface appears dark enhancing the visibility of the bubble.
Patent NZ-550486-A (NZ)
Title: Controlled evacuation ostomy appliance
Inventor: CLINE JOHN
Filed: 2006-10-11
Abstract: Appliances that can be used to control stomal discharge are disclosed. The controlled evacuation ostomy appliance 10 includes an attachment device 16 for attaching the appliance to a wearer's body, a seal 12 that seals against the wearer's stoma 14, and a restraining structure 18 for restraining the seal and for transferring a sealing force or sealing force reaction between the attachment device and the seal. The restraining structure comprises a flexible portion.
Patent NZ-553606-A (NZ)
Title: User interface for travel booking system
Inventor: LY YOUNG
IPC: G06Q10/00
Filed: 2007-03-02
Abstract: A user interface for a travel booking system is disclosed, the user interface enabling a user to query possible journey destinations and comprises: an icon that can be manipulated into a plurality of states, each state corresponding to a price requirement, a window adapted to display a map comprising possible journey destinations. Upon manipulating the icon into a state, the window is adapted to display a map and possible journey destinations on the map with respective journey prices meeting the price requirement corresponding to the icon state. A travel booking system for booking journey tickets is disclosed which comprises: a computer with a user interface as described above and a database in communication with the computer. The database contains information on journey destinations and journey prices, and the computer is adapted to receive information on one or more of the possible journey destinations from the database. The possible journeys relate to journey destinations with respective journey prices meeting the price requirement selected by a user, and the computer is adapted to display a map and the possible journey destinations on the map in the user interface.
Patent NZ-565931-A (NZ)
Title: Power driven wheelchair with motor assembly having main controller on wheelchair and local controller at a seperate location
Inventor: MATTES JOHN
IPC: G05B19/10
Filed: 2006-08-31
Abstract: Disclosed is a power driven wheelchair. The wheelchair comprises a system controller associated with the wheelchair, and a first motor assembly associated with a first drive wheel of the wheelchair and in communication with the system controller over a common bus. The system controller includes a main controller, a storage device, and an input device which communicates with the main controller. The first motor assembly includes a drive motor, a local controller in communication with the drive motor, and a sensor to sense conditions of the motor and communicate with the local controller. The main controller is in a first housing at a first location on the wheelchair, with the local controller in a second housing at a second location on the wheelchair.
Patent NZ-580753-A (NZ)
Title: A stove with an emergency fuel shut-off valve which activates when the stove is tipped
Inventor: WALSH DERMOT
IPC: F24C3/14
Filed: 2008-03-31
Abstract: A stove (1), is disclosed. The stove includes a burner (4), a fuel reservoir (2), a fuel passage communicating between the fuel reservoir (2) and the burner (4), a stop valve (3) in the fuel passage, which is operable to control the supply of fuel from the reservoir to the burner. There is provided a normally open emergency shut-off valve (7) which is operable to close the fuel passage when the stove is tipped away from a normal upstanding operating position by a preset amount.
Patent NZ-581226-A (NZ)
Title: A hinging construction for a bin assembly with hinge having fingers that connect from one panel side to an adjacent panel opposite side
Inventor: BONNER CRAIG RONALD
IPC: B65D19/20
Filed: 2010-11-03
Abstract: For connecting corners of a collapsible bin sides so that sides can be in the same planar orientation when collapsed as well as at right angles when erected a hinge connector is typically made from a blank and has fingers that connect from one side of a bin side panel to the other side of the adjacent side panel. Adjacent fingers typically alternate from one side to the other.
Patent NZ-584577-A (NZ)
Title: Image processing program with automatic filter parameter setting
Inventor: MAEDA HISATO
IPC: G06T5/20
Filed: 2008-08-06
Abstract: A method and system for image processing on nuclear medicine image data is disclosed. The image processing method comprises preparing a cutoff frequency table, which stores a relation between a parameter related to a radial intensity distribution of a spatial frequency of a nuclear medicine image and a Butterworth filter cutoff frequency. The method also comprises inputting and applying a two-dimensional Fourier transform to nuclear medicine image data in order to obtain a spatial frequency of the nuclear medicine image; calculating a radial intensity distribution of the spatial frequency of the nuclear medicine image; determining a cutoff frequency corresponding to a parameter related to the radial intensity distribution determined for the nuclear medicine image, with reference to the cutoff frequency table; and filtering the nuclear medicine image data by means of a Butterworth filter set with the cutoff frequency.
Patent NZ-586655-A (NZ)
Title: A medical dispenser with a display which is covered when dispensing action is in progress
Inventor: BRADSHAW DOUGLAS
IPC: A61J7/00
Filed: 2009-01-21
Abstract: A medicament dispenser such as an asthma inhaler, with an mouth or nasal outlet for dispensing the medicament, a housing containing the medicament doses, a first display for presenting a number or information to the user, and an outlet cover that can be moved by sliding or rotating from a closed position so the first display is visible to an open position so that the display is hidden. The dispenser can have a second indicator display so that the when the first display is covered from view, the second display is visible to the user. The first display indicates the number of doses released or the number of doses remaining in the dispenser. The second display indicates the state of the dispenser, either a dose is ready to be dispensed, a dose has been correctly dispensed, or a dose has been incorrectly dispensed. The two displays have different geometric shapes, and can be openings in the housing and outlet cover, and show mechanically changing indicators.
Patent NZ-586847-A (NZ)
Title: Foam innerspring dampening insertswith at lest five projections
Inventor: DEMOSS LARRY K
IPC: A47C23/04
Filed: 2009-01-16
Abstract: A mattress S with a foam dampened innerspring 10, comprises an innerspring, with at least one foam dampening insert 50 located in the innerspring 10, and padding 72 and upholstery material 70 positioned over a support surface 60 of the innerspring 10 to form a mattress S. The innerspring 10 has a plurality of coils 20 interconnected in an array of columns and rows, the columns of coils 20 being generally equally spaced apart, and the rows of coils 20 being generally equally spaced apart. Each coil has a generally helical wire form body with openings between helical turns of wire of the helical wire form body. The inserts 50 are located in the innerspring 10 between coils 20 of the array. The insert 50 has a central core which fits in a space between a row or column of coils 20 of the array, and at least five segments 50a, 50b, 50c, 50d, 50e which extends laterally from the central core and into one or more openings between the helical turns of wire of the helical wire form bodies of at least two adjacent coils 20 of the array. Three of the at least five segments extend from the central core in a first direction and at three different elevations, and two of the at least five segments extend from the central core in a second direction at different elevations which are different from the three different elevations of the other three segments.
Patent NZ-595938-A (NZ)
Title: Tumor suppression using placental stem cells
Inventor: PALUDAN CASPER
IPC: C12N5/073
Filed: 2007-08-06
Abstract: NZ 595938 Disclosed is a method of suppressing the proliferation of a plurality of tumour cells in vitro comprising contacting said plurality of tumour cells with a plurality of placental stem cells for a time sufficient for said placental stem cells to detectably suppress proliferation of said plurality of tumour cells, as compared to a plurality of said tumour cells not contacted with placental stem cells, wherein said placental stem cells are not totipotent, and wherein said placental stem cells have the features of one or more of the groups (a) to (f): are CD90+ and CD45-; express CD200; express CD200 and HLA-G; express CD73, CD105, and HLA-G; express CD73 and CD105; express OCT-4.
Patent NZ-597325-A (NZ)
Title: Combination therapy of an afucosylated cd20 antibody with fludarabine and/or mitoxantrone
Inventor: HEINRICH DANIEL ALEXANDER
IPC: A61K31/137
Filed: 2010-08-12
Abstract: NZ 597325 Disclosed is the use of an afucosylated anti-CD20 antibody with an amount of fucose of 60% or less of the total amount of oligo saccharides (sugars) at Asn297, for the manufacture of a medicament for the treatment of cancer in combination with fludarabine and/or mitoxantrone, wherein said antibody is a humanised B-Ly1 antibody, and the humanized B-Ly1 antibody is characterised in comprising an amino acid sequence of the variable region of the heavy chain (VH) of SEQ ID NO: 7, and in comprising an amino acid sequence of the variable region of the light chain (VL) of SEQ ID NO: 20; and wherein a) when the humanised B-Ly1 antibody is administered in combination with fludarabine, the antibody is administered in a dosage of 800 to 1600 mg on day 1 of up to six or seven 3-to 4-week-dosage-cycles, and fludarabine is administered in a dosage of 20mg/m2 to 30 mg/m2 on day 1, 2 and 3 of up to six or seven 4-week-dosage-cycles, or b) when the humanised B-Ly1 antibody is administered in combination with fludarabine and cyclophosphamide, the antibody in a dosage of 800 to 1600 mg on day 1 of up to six or seven 3-to 4-week-dosage-cycles, fludarabine is administered in a dosage of 20mg/m2 to 30 mg/m2 on day 1, 2 and 3 of up to six or seven 4-week-dosage-cycles, and cyclophosphamide is administered in a dosage of 200 mg/m2 to 300 mg/m2 on day 1, 2 and 3 of up to six or seven 4-week-dosage-cycles.
Patent NZ-598271-A (NZ)
Title: Use of sarmentine and its analogs for controlling plant pests
Inventor: HUANG HUAZHANG
IPC: A01N57/10
Filed: 2010-07-20
Abstract: 598271 Disclosed herein are methods and compositions for modulating phytopathogenic infection in a plant comprise applying to the plant and/or seeds thereof and/or substrate used for growing said plant an amount of a sarmentine and/or a sarmentine analog having substantially the same activity as sarmentine effective to modulate said phytopathogenic infection via virus, fungi, bacteria, nematode and insect.
Patent NZ-598501-A (NZ)
Title: Grinder container
Inventor: BODUM JORGEN
IPC: A47J42/40
Filed: 2010-02-11
Abstract: A grinder container (10) to be inserted in a coffee grinder comprises a lid (20) having a center inlet hole (26). The lid (20) rests on an opening rim (18) of the grinder container (10) with a peripheral lid rim (21). A peripheral web (30) projects into the interior of the grinder container (10) at a distance to the peripheral lid rim (21) and is opposite an inner wall (X) of the grinder container (10). In order to level out any dimensional tolerances regarding the height of grinder containers, the lid (20) consists of a deformation-resistant center lid part (24) which is produced of a rigid plastic material and comprises the center inlet hole (26) and of an elastically deformable lid part (22) which is produced of a soft rubber material, said lid part being connected to the center lid part (24) and comprising the peripheral web (30).
Patent NZ-599041-A (NZ)
Title: Kinase inhibitors
Inventor: LEE JAEKYOO
IPC: A01N43/54
Filed: 2010-11-12
Abstract: Disclosed herein is a compound of formula (I) wherein the variables are defined in the specification, and the use thereof in the treatment of a protein kinase mediated disease, wherein the disease is treated by inhibiting SYK, PYK2, FAK, ZAP70, PIM1, FLT3, RET, JAK2, JAK3, LRRK2, LRRK2(G2019S), ABLl(T315I), AURKB, AXL, FLT3, KIT, KIT(D816V), KIT(V559D,T670I), MKNK2, MLKl, PDGFRB, PLK3, RET, SNARK, SRPK3, TAKl, or TYK2 signaling. In one embodiment the compound is 4-(3-((dimethylamino)methyl)-4-phenyl-1H-pyrrol-1-yl)-N-(3,5-dimethylphenyl)-5-fluoropyrimidin-2-amine.
Patent NZ-600094-A (NZ)
Title: Method of enhancing muscle protein synthesis
Inventor: HAWLEY JOHN ALAN
IPC: A23L33/00
Filed: 2010-11-29
Abstract: Disclosed is a method of enhancing muscle protein synthesis following physical exertion that includes a repeated exercise that is anaerobic in nature, the method comprising the step of: administering a composition to a human in need thereof, wherein the composition is administered within a time period of from 30 minutes before performing the physical exertion to 30 minutes after performing the physical exertion, the composition comprising: (a) at least one carbohydrate, wherein the at least one carbohydrate is present in an amount in a range of from 50 g to 75 g; (b) a blend of at least one protein and at least one essential amino acid, wherein the at least one protein is present in an amount in a range of from 10 g to 50 g, and wherein the at least one essential amino acid is present in an amount in a range of from 5 g to 25 g; and (c) wherein (a) and (b) are present in an (a) to (b) ratio in a range of from 1:1 to 3:1.
Patent NZ-603929-A (NZ)
Title: Methods for producing low oxygen biomass-derived pyrolysis oils
Inventor: TRAYNOR THOMAS
IPC: C10G3/00
Filed: 2011-07-20
Abstract: Abstract – 603929 Disclosed herein is a method (10) for producing low oxygen biomass-derived pyrolysis oil, the method comprising the steps of: reducing one or more of the solids content of biomass-derived pyrolysis oil to less than 0.10%; the total metals content thereof to less than 100 ppm., and the water content thereof to less than 20 weight percent (wt. %), the steps of reducing the one or more of the solids content, the metals content, and the water content producing a treated biomass-derived pyrolysis oil (250); and deoxygenating the treated biomass-derived pyrolysis oil (400). Wherein the step of deoxygenating preferably comprises deoxygenating in the presence of hydrogen-containing gas and a first catalyst having a neutral catalyst support at first hydroprocessing conditions comprising a reaction temperature in the range of 100°C to 400°C, a pressure of 3204 kPa to 12410 kPa (450 to 1800 psig), a liquid hourly space velocity of 0.25 volume of liquid feed/volume of catalyst/hour (V/V/Hr) to 1.0 V/V/Hr, and a hydrogen-containing gas treat rate of 1000 SCFIB to 12000 SCFIB (400).
Patent NZ-613306-A (NZ)
Title: A hybridoma cell line 10g4 and a monoclonal antibody against the total of aflatoxin b1, b2, g1 and g2
Inventor: LI PEIWU
IPC: C07K16/14
Filed: 2013-01-17
Abstract: Disclosed is a a hybridoma cell line 10G4 deposited at the China Center for Type Culture Collection (CCTCC) with the CCTCC accession number of C201016. Also disclosed is a monoclonal antibody against total aflatoxin B1, B2, G1 and G2, wherein the monoclonal antibody is produced by hybridoma cell line 10G4 that is deposited at the China Center for Type Culture Collection (CCTCC) with the CCTCC accession number of C201016.
Patent NZ-625991-A (NZ)
Title: Pteridines and their use as agrochemicals
Inventor: YERKES CARLA
IPC: C07D487/04
Filed: 2009-08-31
Abstract: The present disclosure relates to pteridine compounds and their use as agrochemicals and animal health products. Compounds of the disclosure include: 4-{ 2-[4-(4-Trifluoromethylpyridin-2-yloxy)-phenyl]-ethoxy} -pteridine and { 2-[4-(4-tert-Butylpyridin-2-yloxy)-phenyll-ethyl} -pteridin-4-ylamine.
Patent NZ-629196-A (NZ)
Title: Devices for dispensing surgical fasteners into tissue while simultaneously generating external marks that mirror the number and location of the dispensed surgical fasteners
Inventor: STRAEHNZ JENS-PETER
IPC: A61B17/068
Filed: 2013-03-13
Abstract: A device dispenses surgical fasteners inside a body and generates marks outside the body indicating where the surgical fasteners have been dispensed inside the body. The device includes a first member having a surgical fastener dispenser opening, and a second member coupled with the first member, the second member having a distal end that opposes the surgical fastener dispenser opening. The second member acts to support the external surface of the tissue to be fastened while the first member dispenses a fastener. The device may include a clamp for compressing tissue between the marking assembly and the surgical fastener dispenser. The device includes a marking assembly (142) secured to the distal end of the second member. The marking assembly includes a marker (182) for generating marks on an external surface that mirror the location of each surgical fastener dispensed from the surgical fastener dispenser opening. The marker may be in the form of an ink marker adapted to form an ink mark on the patients skin as a fastener is dispensed.
Patent NZ-700546-A (NZ)
Title: Use of neuregulin to treat peripheral nerve injury
Inventor: CAGGIANO ANTHONY O
IPC: A61P25/02
Filed: 2013-03-29
Abstract: The present invention relates generally to the fields of molecular biology, regenerative medicine and nerve trauma injury. In particular, the present invention provides compositions comprising neuregulin-1 (NRG1) and methods of use thereof for preventing or ameliorating a sign or symptom of peripheral nerve injury or neuropathic pain or for treating peripheral nerve injury or neuropathic pain.
Patent NZ-702237-A (NZ)
Title: Prodrug of fluorine-containing amino acid
Inventor: MIYAKOSHI NAOKI
IPC: C07D317/40
Filed: 2013-05-31
Abstract: Provided are a fluorine-containing amino acid prodrug represented by general formula (I) that makes a fluorine-containing amino acid which is a group 2 metabotropic glutamate receptor agonist into a prodrug, or a pharmacologically acceptable salt thereof. More specifically, provided is a prodrug that increases the in vivo exposure and heightens the oral absorbability and other such mucosal absorbability of a novel compound that acts on group 2 metabotropic glutamate receptors as an agent for the treatment or prevention of conditions in which group 2 metabotropic glutamate receptors are said to participate, such as: schizophrenia, anxiety disorder and related conditions, depression, bipolar disorder, epilepsy, developmental disorders, sleep disorders, and other such neuropsychiatric conditions; and drug dependence, cognitive disorders, Alzheimer’s disease, Huntington’s chorea, Parkinson’s disease, movement disorders associated with muscular rigidity, cerebral ischemia, cerebral insufficiency, spinal cord disorders, cephalopathy, and other such neurological conditions.
Patent NZ-702253-A (NZ)
Title: Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors
Inventor: HILPERT HANS
IPC: C07D413/12
Filed: 2013-06-24
Abstract: The present invention provides difluoro-cyclopentaoxazinyls and difluorobenzooxazinyls of formula (I) having BACE1 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer’s disease.
Patent NZ-706748-A (NZ)
Title: System and method to process transactions at retail fueling stations using a mobile device
Inventor: CHITTENDEN THOMAS SHERFEY
IPC: G07F15/00
Filed: 2013-10-04
Abstract: A method of processing a transaction includes receiving a site location code. Site configuration information corresponding to the received site location code is received from a database. That information includes more product record(s), each corresponding to a reservable product or a non-reservable product. A selection of one or more of the product records in the retrieved information is received. If any selected product record corresponds to a reservable product, a reservation command is produced. That command requests reservation of selected reservable product(s). A method of selecting a product includes receiving a location input and determining a site location code with it. The site location code is transmitted and one or more product records are received. Representations of one or more of the received product records are presented and a selection of products is received. An indication of the selection is transmitted.